Karl Axel Staffan Eriksson
Fondateur chez Alertix Veterinary Diagnostics AB
Profil
Karl Axel Staffan Eriksson is the founder of two companies.
He founded AroCell AB in 2003 and served as the Chief Scientific Officer from 2020 to 2021.
He also founded Alertix Veterinary Diagnostics AB in 2017 and currently holds the title of Director, Vice President-Research & Development.
Dr. Eriksson's former job was as a Professor at the Swedish University of Agricultural Sciences from 2000 to 2012.
Dr. Eriksson holds a doctorate degree from both Karolinska Institutet and the Swedish University of Agricultural Sciences.
Postes actifs de Karl Axel Staffan Eriksson
| Sociétés | Poste | Début |
|---|---|---|
Alertix Veterinary Diagnostics AB
 Alertix Veterinary Diagnostics AB Medical SpecialtiesHealth Technology Alertix Veterinary Diagnostics AB engages in developing and marketing of an assay for early detection and monitoring of cancer diseases in pets. Its products include Alertix Canine, Alertix Feline and Alertix Equine. The company was founded by Bengt Helge Emil Astrand, Karl Axel Staffan Eriksson and Saga Anne-Charlotte Aronsson in 2017 and is headquartered in Kalmar, Sweden. | Fondateur | 01/01/2017 |
Anciens postes connus de Karl Axel Staffan Eriksson
| Sociétés | Poste | Fin |
|---|---|---|
| AROCELL AB | Fondateur | 01/01/2020 |
| Swedish University of Agricultural Sciences | Corporate Officer/Principal | - |
Formation de Karl Axel Staffan Eriksson
| Swedish University of Agricultural Sciences | Doctorate Degree |
| Karolinska Institutet | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AROCELL AB | Health Technology |
| Entreprise privées | 1 |
|---|---|
Alertix Veterinary Diagnostics AB
Alertix Veterinary Diagnostics AB Medical SpecialtiesHealth Technology Alertix Veterinary Diagnostics AB engages in developing and marketing of an assay for early detection and monitoring of cancer diseases in pets. Its products include Alertix Canine, Alertix Feline and Alertix Equine. The company was founded by Bengt Helge Emil Astrand, Karl Axel Staffan Eriksson and Saga Anne-Charlotte Aronsson in 2017 and is headquartered in Kalmar, Sweden. | Health Technology |